Search research articles
Contact Us
Filters
Showing results (31-40 of 38) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 38 results.
European Review for Medical and Pharmacological Sciences
|
April 25, 2020
Association of major adverse cardiovascular events and cardiac troponin-I levels following percutaneous coronary intervention: a three-year follow-up study at a single center
Z-S Huang, Z-D Zheng, J-W Zhang, et al.
Journal of Biological Regulators and Homeostatic Agents
|
July 9, 2014
Environmental risk factors for women with polycystic ovary syndrome in china: a population-based case-control study
J Zhang, X F Liu, Y Liu, et al.
Nucleosides, Nucleotides & Nucleic Acids
|
June 15, 2010
Thymidine kinase 1 is a potential marker for prognosis and monitoring the response to treatment of patients with breast, lung, and esophageal cancer and non-Hodgkin's lymphoma
E He, X H Xu, H Guan, et al.
European Review for Medical and Pharmacological Sciences
|
September 20, 2018
The clinical observation of verapamil in combination with interventional chemotherapy in advanced gastric cancer
G-F Fan, J-J Pan, P-S Fan, et al.
Genetics and Molecular Research : GMR
|
July 1, 2015
Positive association between PPARD rs2016520 polymorphism and coronary heart disease in a Han Chinese population
H D Ye, Y R Li, Q X Hong, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 9, 2018
Identification and validation of novel microenvironment-based immune molecular subgroups of head and neck squamous cell carcinoma: implications for immunotherapy
Y-P Chen, Y-Q Wang, J-W Lv, et al.
The British Journal of Dermatology
|
February 2, 2017
Multiple variants in 5q31.1 are associated with systemic lupus erythematosus susceptibility and subphenotypes in the Han Chinese population
L L Wen, Z W Zhu, C Yang, et al.
Zhonghua Yi Xue Za Zhi
|
May 11, 2018
[A multicenter, randomized, controlled, phase Ⅳ clinical study of PEG-rhG-CSF for preventing chemotherapy induced neutropenia in patients with breast cancer]
Z F Jiang, F R Xu, J Fan, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 38) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 38 results.
European Review for Medical and Pharmacological Sciences
|
April 25, 2020
Association of major adverse cardiovascular events and cardiac troponin-I levels following percutaneous coronary intervention: a three-year follow-up study at a single center
Z-S Huang, Z-D Zheng, J-W Zhang, et al.
Journal of Biological Regulators and Homeostatic Agents
|
July 9, 2014
Environmental risk factors for women with polycystic ovary syndrome in china: a population-based case-control study
J Zhang, X F Liu, Y Liu, et al.
Nucleosides, Nucleotides & Nucleic Acids
|
June 15, 2010
Thymidine kinase 1 is a potential marker for prognosis and monitoring the response to treatment of patients with breast, lung, and esophageal cancer and non-Hodgkin's lymphoma
E He, X H Xu, H Guan, et al.
European Review for Medical and Pharmacological Sciences
|
September 20, 2018
The clinical observation of verapamil in combination with interventional chemotherapy in advanced gastric cancer
G-F Fan, J-J Pan, P-S Fan, et al.
Genetics and Molecular Research : GMR
|
July 1, 2015
Positive association between PPARD rs2016520 polymorphism and coronary heart disease in a Han Chinese population
H D Ye, Y R Li, Q X Hong, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 9, 2018
Identification and validation of novel microenvironment-based immune molecular subgroups of head and neck squamous cell carcinoma: implications for immunotherapy
Y-P Chen, Y-Q Wang, J-W Lv, et al.
The British Journal of Dermatology
|
February 2, 2017
Multiple variants in 5q31.1 are associated with systemic lupus erythematosus susceptibility and subphenotypes in the Han Chinese population
L L Wen, Z W Zhu, C Yang, et al.
Zhonghua Yi Xue Za Zhi
|
May 11, 2018
[A multicenter, randomized, controlled, phase Ⅳ clinical study of PEG-rhG-CSF for preventing chemotherapy induced neutropenia in patients with breast cancer]
Z F Jiang, F R Xu, J Fan, et al.
Page
of 4